ML4302 - Clinical Biochemistry 2
| Credit points: | 03 |
| Year: | 2019 |
| Student Contribution Band: | Band 2 |
| Administered by: |
This subject continues from ML4301 in the study of the clinical aspects of biochemical analysis. Endocrine function and analysis of disorders, protein and immunoglobulin determination, therapeutic drug monitoring and tumour markers, iron and lipid disorders. The issues of enzyme analysis and immunoassays will be discussed and practised. Advanced analytical methods will be introduced. The subject will use case study tutorial sessions to facilitate the teaching of the clinical interpretation of results. This subject completes the professional competency required for a graduate clinical biochemistry, medical laboratory scientist.
Learning Outcomes
- demonstrate an integrated theoretical and technical knowledge of basic methods of clinical chemical analysis;
- demonstrate an integrated theoretical and technical knowledge of quality assurance application and interpretation;
- apply recognized methods and tools of clinical biochemistry in a clinical/medical investigative context;
- reflect on current skills, knowledge and attitudes, in order to plan and implement ongoing personal and professional development needs, relevant to clinical biochemistry and working as a professional medical laboratory scientist.
| Prerequisites: | PP2101 and PP2201 |
Availabilities | |
| Townsville, , Study Period 8 | |
| Census Date 15-Aug-2019 | |
| Face to face teaching 12-Aug-2019 to 09-Sep-2019 | |
| Contact hours: |
|
| Assessment: | end of semester exam (50%); other exams (30%); assignments (20%). |
Note: Minor variations might occur due to the continuous Subject quality improvement process, and in case of minor variation(s) in assessment details, the Subject Outline represents the latest official information.